Introduction: A novel human corona virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), was identified in Wuhan, China, in December 2019. Since then, the virus has made its way across the globe to affect over 180 countries. SARS-CoV-2 has infected humans in all age groups, of all ethnicities, both males and females while spreading through communities at an alarming rate. Given the nature of this virus, there is much still to be learned; however, we know that the clinical manifestations range from a common cold to more severe diseases such as bronchitis, pneumonia, severe acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. It is believed that COVID-19, in those with underlying health conditions or co morbidities, has an increasingly rapid and severe progression, often leading to death. Aims and Objectives: A retrospective study was carried out in COVID-19 patients. Data was collected by record review. Patients of all age groups of both gender diagnosed with COVID-19 positive were included. Clinical characteristics and co morbidities was analyzed. Results: A total number of 75 patients were diagnosed with COVID-19 positive with one or more warning signs were admitted during the study period. Majority of the cases admitted are more than 41(85%) years of age. Highest admitted gender is male 52(69%).Most common signs and symptoms is fever 66(88%).Maximum number of patients have comorbidites53(71%) of hypertension36(48%) and diabetius35(47%). Most of the admitted cases have two comorbidites 23(31%).